Dorthe Grønnegaard Mejer has an M.Sc. in Pharmaceutical Sciences from Copenhagen University. She has previously held several positions across different clinical development disciplines as well as positions within clinical oncology development in other biotech companies such as Genmab, Larix, Orphazyme, and Oncology Venture.
This person is not in any teams
This person is not in any offices